Alzheimer’s disease alters the transcriptomic profile of natural killer cells at single-cell resolution
Alzheimer’s disease (AD) is the most common dementia without an effective cure at least partially due to incomplete understanding of the disease. Inflammation has emerged as a central player in the onset and progression of AD. As innate lymphoid cells, natural killer (NK) cells orchestrate the initi...
Gespeichert in:
| Veröffentlicht in: | Frontiers in immunology Jg. 13; S. 1004885 |
|---|---|
| Hauptverfasser: | , , , , , , |
| Format: | Journal Article |
| Sprache: | Englisch |
| Veröffentlicht: |
Switzerland
Frontiers Media S.A
02.11.2022
|
| Schlagworte: | |
| ISSN: | 1664-3224, 1664-3224 |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| Abstract | Alzheimer’s disease (AD) is the most common dementia without an effective cure at least partially due to incomplete understanding of the disease. Inflammation has emerged as a central player in the onset and progression of AD. As innate lymphoid cells, natural killer (NK) cells orchestrate the initiation and evolution of inflammatory responses. Yet, the transcriptomic features of NK cells in AD remain poorly understood. We assessed the diversity of NK cells using web-based single-cell RNA sequencing data of blood NK cells from patients with AD and control subjects and flow cytometry. We identified a contraction of NK cell compartment in AD, accompanied by a reduction of cytotoxicity. Unbiased clustering revealed four subsets of NK cells in AD, i.e., CD56
bright
NK cells, CD56
dim
effector NK cells, adaptive NK cells, and a unique NK cell subset that is expanded and characterized by upregulation of CX3CR1, TBX21, MYOM2, DUSP1, and ZFP36L2, and negatively correlated with cognitive function in AD patients. Pseudo-temporal analysis revealed that this unique NK cell subset was at a late stage of NK cell development and enriched with transcription factors TBX21, NFATC2, and SMAD3. Together, our study identified a distinct NK cell subset and its potential involvement in AD. |
|---|---|
| AbstractList | Alzheimer's disease (AD) is the most common dementia without an effective cure at least partially due to incomplete understanding of the disease. Inflammation has emerged as a central player in the onset and progression of AD. As innate lymphoid cells, natural killer (NK) cells orchestrate the initiation and evolution of inflammatory responses. Yet, the transcriptomic features of NK cells in AD remain poorly understood. We assessed the diversity of NK cells using web-based single-cell RNA sequencing data of blood NK cells from patients with AD and control subjects and flow cytometry. We identified a contraction of NK cell compartment in AD, accompanied by a reduction of cytotoxicity. Unbiased clustering revealed four subsets of NK cells in AD, i.e., CD56
NK cells, CD56
effector NK cells, adaptive NK cells, and a unique NK cell subset that is expanded and characterized by upregulation of CX3CR1, TBX21, MYOM2, DUSP1, and ZFP36L2, and negatively correlated with cognitive function in AD patients. Pseudo-temporal analysis revealed that this unique NK cell subset was at a late stage of NK cell development and enriched with transcription factors TBX21, NFATC2, and SMAD3. Together, our study identified a distinct NK cell subset and its potential involvement in AD. Alzheimer’s disease (AD) is the most common dementia without an effective cure at least partially due to incomplete understanding of the disease. Inflammation has emerged as a central player in the onset and progression of AD. As innate lymphoid cells, natural killer (NK) cells orchestrate the initiation and evolution of inflammatory responses. Yet, the transcriptomic features of NK cells in AD remain poorly understood. We assessed the diversity of NK cells using web-based single-cell RNA sequencing data of blood NK cells from patients with AD and control subjects and flow cytometry. We identified a contraction of NK cell compartment in AD, accompanied by a reduction of cytotoxicity. Unbiased clustering revealed four subsets of NK cells in AD, i.e., CD56bright NK cells, CD56dim effector NK cells, adaptive NK cells, and a unique NK cell subset that is expanded and characterized by upregulation of CX3CR1, TBX21, MYOM2, DUSP1, and ZFP36L2, and negatively correlated with cognitive function in AD patients. Pseudo-temporal analysis revealed that this unique NK cell subset was at a late stage of NK cell development and enriched with transcription factors TBX21, NFATC2, and SMAD3. Together, our study identified a distinct NK cell subset and its potential involvement in AD. Alzheimer's disease (AD) is the most common dementia without an effective cure at least partially due to incomplete understanding of the disease. Inflammation has emerged as a central player in the onset and progression of AD. As innate lymphoid cells, natural killer (NK) cells orchestrate the initiation and evolution of inflammatory responses. Yet, the transcriptomic features of NK cells in AD remain poorly understood. We assessed the diversity of NK cells using web-based single-cell RNA sequencing data of blood NK cells from patients with AD and control subjects and flow cytometry. We identified a contraction of NK cell compartment in AD, accompanied by a reduction of cytotoxicity. Unbiased clustering revealed four subsets of NK cells in AD, i.e., CD56bright NK cells, CD56dim effector NK cells, adaptive NK cells, and a unique NK cell subset that is expanded and characterized by upregulation of CX3CR1, TBX21, MYOM2, DUSP1, and ZFP36L2, and negatively correlated with cognitive function in AD patients. Pseudo-temporal analysis revealed that this unique NK cell subset was at a late stage of NK cell development and enriched with transcription factors TBX21, NFATC2, and SMAD3. Together, our study identified a distinct NK cell subset and its potential involvement in AD.Alzheimer's disease (AD) is the most common dementia without an effective cure at least partially due to incomplete understanding of the disease. Inflammation has emerged as a central player in the onset and progression of AD. As innate lymphoid cells, natural killer (NK) cells orchestrate the initiation and evolution of inflammatory responses. Yet, the transcriptomic features of NK cells in AD remain poorly understood. We assessed the diversity of NK cells using web-based single-cell RNA sequencing data of blood NK cells from patients with AD and control subjects and flow cytometry. We identified a contraction of NK cell compartment in AD, accompanied by a reduction of cytotoxicity. Unbiased clustering revealed four subsets of NK cells in AD, i.e., CD56bright NK cells, CD56dim effector NK cells, adaptive NK cells, and a unique NK cell subset that is expanded and characterized by upregulation of CX3CR1, TBX21, MYOM2, DUSP1, and ZFP36L2, and negatively correlated with cognitive function in AD patients. Pseudo-temporal analysis revealed that this unique NK cell subset was at a late stage of NK cell development and enriched with transcription factors TBX21, NFATC2, and SMAD3. Together, our study identified a distinct NK cell subset and its potential involvement in AD. Alzheimer’s disease (AD) is the most common dementia without an effective cure at least partially due to incomplete understanding of the disease. Inflammation has emerged as a central player in the onset and progression of AD. As innate lymphoid cells, natural killer (NK) cells orchestrate the initiation and evolution of inflammatory responses. Yet, the transcriptomic features of NK cells in AD remain poorly understood. We assessed the diversity of NK cells using web-based single-cell RNA sequencing data of blood NK cells from patients with AD and control subjects and flow cytometry. We identified a contraction of NK cell compartment in AD, accompanied by a reduction of cytotoxicity. Unbiased clustering revealed four subsets of NK cells in AD, i.e., CD56 bright NK cells, CD56 dim effector NK cells, adaptive NK cells, and a unique NK cell subset that is expanded and characterized by upregulation of CX3CR1, TBX21, MYOM2, DUSP1, and ZFP36L2, and negatively correlated with cognitive function in AD patients. Pseudo-temporal analysis revealed that this unique NK cell subset was at a late stage of NK cell development and enriched with transcription factors TBX21, NFATC2, and SMAD3. Together, our study identified a distinct NK cell subset and its potential involvement in AD. |
| Author | Qi, Caiyun Zhang, Nan Li, Handong Liu, Qiang Zhang, Wenjun Liu, Fang Han, Yali |
| AuthorAffiliation | Department of Neurology, Tianjin Neurological Institute, Tianjin Medical University General Hospital , Tianjin , China |
| AuthorAffiliation_xml | – name: Department of Neurology, Tianjin Neurological Institute, Tianjin Medical University General Hospital , Tianjin , China |
| Author_xml | – sequence: 1 givenname: Caiyun surname: Qi fullname: Qi, Caiyun – sequence: 2 givenname: Fang surname: Liu fullname: Liu, Fang – sequence: 3 givenname: Wenjun surname: Zhang fullname: Zhang, Wenjun – sequence: 4 givenname: Yali surname: Han fullname: Han, Yali – sequence: 5 givenname: Nan surname: Zhang fullname: Zhang, Nan – sequence: 6 givenname: Qiang surname: Liu fullname: Liu, Qiang – sequence: 7 givenname: Handong surname: Li fullname: Li, Handong |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/36405736$$D View this record in MEDLINE/PubMed |
| BookMark | eNp9Ustu1DAUjVARLaU_wAJ5yWYGJ37E2SBVFYVKldjA2rqxr2dcnHiwHaSy4jf4vX4JSWeoWhZ4Y1_7nHOte87L6miMI1bV65quGVPdO-eHYVo3tGnWNaVcKfGsOqml5CvWNPzo0fm4Osv5hs6Ld4wx8aI6ZpJT0TJ5Uvnz8HOLfsB09-t3JtZnhIwEQsGUSdkiKQnGbJLflTh4Q3YpOh-QREdGKFOCQL75EDARgyFkAoVkP24CrpaaJMwxTMXH8VX13EHIeHbYT6uvlx--XHxaXX_-eHVxfr0yXKqyks62znAmkNVgTGOFAOWooyipVJxaBHA163rllOSoesulMdz20DMKgrPT6mqvayPc6F3yA6RbHcHr-4uYNhpS8SagboXsJdimo23HQdCeis4qrGXjqG1x0Xq_19pN_YDW4DhPIzwRffoy-q3exB-6k1K2opsF3h4EUvw-YS568HkZDIwYp6yblqnZFa7oDH3zuNdDk79ezYBmDzAp5pzQPUBqqpdM6PtM6CUT-pCJmaT-IRlfYPFj_q8P_6P-Af95wUA |
| CitedBy_id | crossref_primary_10_1016_j_isci_2024_110235 crossref_primary_10_3389_fnagi_2024_1477327 crossref_primary_10_3389_fimmu_2025_1616939 crossref_primary_10_1186_s12964_023_01324_9 crossref_primary_10_1111_ejn_70096 crossref_primary_10_1007_s44192_025_00128_2 crossref_primary_10_1016_j_biopha_2024_116884 crossref_primary_10_3390_ijms25094609 crossref_primary_10_1186_s12974_024_03040_8 crossref_primary_10_3389_fimmu_2025_1616899 crossref_primary_10_3389_fnmol_2023_1280639 crossref_primary_10_3390_cells13191624 crossref_primary_10_1038_s41467_024_50472_0 crossref_primary_10_1186_s13195_023_01329_z crossref_primary_10_1111_jnc_16106 crossref_primary_10_1186_s12979_024_00445_0 crossref_primary_10_1186_s13024_025_00798_0 crossref_primary_10_1038_s41598_024_80755_x crossref_primary_10_1007_s12035_024_04126_3 crossref_primary_10_1007_s12035_025_05111_0 crossref_primary_10_1186_s12967_023_04254_9 crossref_primary_10_1177_13872877241295316 crossref_primary_10_1016_j_nbd_2023_106156 crossref_primary_10_1016_j_neurot_2024_e00519 crossref_primary_10_1038_s41598_024_66523_x crossref_primary_10_1002_alz_14348 crossref_primary_10_1093_discim_kyad015 crossref_primary_10_1002_efd2_145 |
| Cites_doi | 10.1038/s43587-022-00198-9 10.1016/j.jneuroim.2005.02.011 10.3389/fimmu.2021.768966 10.1016/j.immuni.2018.09.009 10.2147/jir.s4397 10.1038/s41467-019-14118-w 10.1038/s41467-019-11947-7 10.1038/s41423-020-00574-8 10.1038/nn.4211 10.1038/s41590-018-0212-1 10.1002/ana.22339 10.1038/nm.3913 10.1101/cshperspect.a006346 10.1038/s41593-020-00745-w 10.1016/j.ebiom.2020.102686 10.1038/ni.3368 10.4049/jimmunol.2000037 10.3389/fimmu.2021.645666 10.4049/jimmunol.1300090 10.1523/JNEUROSCI.0829-08.2008 10.1523/JNEUROSCI.0616-08.2008 10.1016/j.cell.2021.04.048 |
| ContentType | Journal Article |
| Copyright | Copyright © 2022 Qi, Liu, Zhang, Han, Zhang, Liu and Li. Copyright © 2022 Qi, Liu, Zhang, Han, Zhang, Liu and Li 2022 Qi, Liu, Zhang, Han, Zhang, Liu and Li |
| Copyright_xml | – notice: Copyright © 2022 Qi, Liu, Zhang, Han, Zhang, Liu and Li. – notice: Copyright © 2022 Qi, Liu, Zhang, Han, Zhang, Liu and Li 2022 Qi, Liu, Zhang, Han, Zhang, Liu and Li |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 5PM DOA |
| DOI | 10.3389/fimmu.2022.1004885 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ: Directory of Open Access Journal (DOAJ) |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE MEDLINE - Academic CrossRef |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Biology |
| EISSN | 1664-3224 |
| ExternalDocumentID | oai_doaj_org_article_756b6ad290794a50b059d8e162f0d7e4 PMC9666759 36405736 10_3389_fimmu_2022_1004885 |
| Genre | Research Support, Non-U.S. Gov't Journal Article |
| GroupedDBID | 53G 5VS 9T4 AAFWJ AAKDD AAYXX ACGFO ACGFS ADBBV ADRAZ AENEX AFPKN ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BCNDV CITATION DIK EBS EMOBN GROUPED_DOAJ GX1 HYE KQ8 M48 M~E OK1 PGMZT RNS RPM ACXDI CGR CUY CVF ECM EIF IPNFZ NPM RIG 7X8 5PM |
| ID | FETCH-LOGICAL-c468t-6fd7fc435e31acc2d55a8f0f0e606840deaaf139b8f864e8bd46cc4dbab30a543 |
| IEDL.DBID | DOA |
| ISICitedReferencesCount | 33 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000885627000001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1664-3224 |
| IngestDate | Fri Oct 03 12:39:13 EDT 2025 Tue Sep 30 17:17:52 EDT 2025 Fri Sep 05 07:01:14 EDT 2025 Thu Apr 03 07:03:31 EDT 2025 Tue Nov 18 21:44:54 EST 2025 Sat Nov 29 03:28:14 EST 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Keywords | single cell sequencing Alzheimer’s disease innate immunity natural killer cell cytotoxicity |
| Language | English |
| License | Copyright © 2022 Qi, Liu, Zhang, Han, Zhang, Liu and Li. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c468t-6fd7fc435e31acc2d55a8f0f0e606840deaaf139b8f864e8bd46cc4dbab30a543 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Edited by: Lan Wu, Vanderbilt University Medical Center, United States This article was submitted to NK and Innate Lymphoid Cell Biology, a section of the journal Frontiers in Immunology Reviewed by: Anil Shanker, Meharry Medical College, United States; Seokmann Hong, Sejong University, South Korea; Lindsay Celada, Baylor College of Medicine, United States |
| OpenAccessLink | https://doaj.org/article/756b6ad290794a50b059d8e162f0d7e4 |
| PMID | 36405736 |
| PQID | 2738493480 |
| PQPubID | 23479 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_756b6ad290794a50b059d8e162f0d7e4 pubmedcentral_primary_oai_pubmedcentral_nih_gov_9666759 proquest_miscellaneous_2738493480 pubmed_primary_36405736 crossref_primary_10_3389_fimmu_2022_1004885 crossref_citationtrail_10_3389_fimmu_2022_1004885 |
| PublicationCentury | 2000 |
| PublicationDate | 2022-11-02 |
| PublicationDateYYYYMMDD | 2022-11-02 |
| PublicationDate_xml | – month: 11 year: 2022 text: 2022-11-02 day: 02 |
| PublicationDecade | 2020 |
| PublicationPlace | Switzerland |
| PublicationPlace_xml | – name: Switzerland |
| PublicationTitle | Frontiers in immunology |
| PublicationTitleAlternate | Front Immunol |
| PublicationYear | 2022 |
| Publisher | Frontiers Media S.A |
| Publisher_xml | – name: Frontiers Media S.A |
| References | Wyss-Coray (B3) 2012; 2 Hao (B10) 2021; 184 Luo (B11) 2022; 2 Hao (B8) 2011; 69 Yang (B15) 2019; 10 Cai (B16) 2020; 53 Zenaro (B6) 2015; 21 Ponzetta (B19) 2013; 191 Lu (B21) 2021; 12 Liu (B22) 2016; 19 Maier (B2) 2008; 28 Xu (B7) 2005; 163 Crinier (B14) 2021; 18 McAlpine (B1) 2008; 1 Crinier (B13) 2018; 49 Hickman (B4) 2008; 28 Schafflick (B12) 2020; 11 Xu (B9) 2021; 12 Zhang (B20) 2020; 205 Song (B5) 2018; 19 Bjorklund (B17) 2016; 17 Jin (B23) 2021; 24 Ponzetta (B18) 2013; 191 |
| References_xml | – volume: 2 year: 2022 ident: B11 article-title: Multidimensional single-cell analysis of human peripheral blood reveals characteristic features of the immune system landscape in aging and frailty publication-title: Nat Aging doi: 10.1038/s43587-022-00198-9 – volume: 163 start-page: 24 year: 2005 ident: B7 article-title: Mechanism of natural killer (Nk) cell regulatory role in experimental autoimmune encephalomyelitis publication-title: J Neuroimmunol doi: 10.1016/j.jneuroim.2005.02.011 – volume: 12 year: 2021 ident: B21 article-title: Expression of immune related genes and possible regulatory mechanisms in alzheimer's disease publication-title: Front Immunol doi: 10.3389/fimmu.2021.768966 – volume: 49 start-page: 971 year: 2018 ident: B13 article-title: High-dimensional single-cell analysis identifies organ-specific signatures and conserved nk cell subsets in humans and mice publication-title: Immunity doi: 10.1016/j.immuni.2018.09.009 – volume: 1 start-page: 29 year: 2008 ident: B1 article-title: Neuroinflammation and tumor necrosis factor signaling in the pathophysiology of alzheimer's disease publication-title: J Inflamm Res doi: 10.2147/jir.s4397 – volume: 11 start-page: 247 year: 2020 ident: B12 article-title: Integrated single cell analysis of blood and cerebrospinal fluid leukocytes in multiple sclerosis publication-title: Nat Commun doi: 10.1038/s41467-019-14118-w – volume: 10 start-page: 3931 year: 2019 ident: B15 article-title: Heterogeneity of human bone marrow and blood natural killer cells defined by single-cell transcriptome publication-title: Nat Commun doi: 10.1038/s41467-019-11947-7 – volume: 18 year: 2021 ident: B14 article-title: Single-cell profiling reveals the trajectories of natural killer cell differentiation in bone marrow and a stress signature induced by acute myeloid leukemia publication-title: Cell Mol Immunol doi: 10.1038/s41423-020-00574-8 – volume: 19 year: 2016 ident: B22 article-title: Neural stem cells sustain natural killer cells that dictate recovery from brain inflammation publication-title: Nat Neurosci doi: 10.1038/nn.4211 – volume: 19 year: 2018 ident: B5 article-title: The identity and function of microglia in neurodegeneration publication-title: Nat Immunol doi: 10.1038/s41590-018-0212-1 – volume: 69 year: 2011 ident: B8 article-title: Interleukin-2/Interleukin-2 antibody therapy induces target organ natural killer cells that inhibit central nervous system inflammation publication-title: Ann Neurol doi: 10.1002/ana.22339 – volume: 21 year: 2015 ident: B6 article-title: Neutrophils promote alzheimer's disease-like pathology and cognitive decline Via lfa-1 integrin publication-title: Nat Med doi: 10.1038/nm.3913 – volume: 2 year: 2012 ident: B3 article-title: Inflammation in Alzheimer disease-a brief review of the basic science and clinical literature publication-title: Cold Spring Harb Perspect Med doi: 10.1101/cshperspect.a006346 – volume: 24 start-page: 61 year: 2021 ident: B23 article-title: Neuroblast senescence in the aged brain augments natural killer cell cytotoxicity leading to impaired neurogenesis and cognition publication-title: Nat Neurosci doi: 10.1038/s41593-020-00745-w – volume: 53 year: 2020 ident: B16 article-title: Single-cell transcriptomics of blood reveals a natural killer cell subset depletion in tuberculosis publication-title: EBioMedicine doi: 10.1016/j.ebiom.2020.102686 – volume: 17 year: 2016 ident: B17 article-title: The heterogeneity of human Cd127(+) innate lymphoid cells revealed by single-cell rna sequencing publication-title: Nat Immunol doi: 10.1038/ni.3368 – volume: 205 year: 2020 ident: B20 article-title: Depletion of nk cells improves cognitive function in the Alzheimer disease mouse model publication-title: J Immunol doi: 10.4049/jimmunol.2000037 – volume: 12 year: 2021 ident: B9 article-title: Single-cell rna sequencing of peripheral blood reveals immune cell signatures in alzheimer's disease publication-title: Front Immunol doi: 10.3389/fimmu.2021.645666 – volume: 191 year: 2013 ident: B18 article-title: Cx3cr1 regulates the maintenance of Klrg1+ nk cells into the bone marrow by promoting their entry into circulation publication-title: J Immunol doi: 10.4049/jimmunol.1300090 – volume: 28 year: 2008 ident: B2 article-title: Complement C3 deficiency leads to accelerated amyloid beta plaque deposition and neurodegeneration and modulation of the Microglia/Macrophage phenotype in amyloid precursor protein transgenic mice publication-title: J Neurosci doi: 10.1523/JNEUROSCI.0829-08.2008 – volume: 28 year: 2008 ident: B4 article-title: Microglial dysfunction and defective beta-amyloid clearance pathways in aging alzheimer's disease mice publication-title: J Neurosci doi: 10.1523/JNEUROSCI.0616-08.2008 – volume: 184 start-page: 3573 year: 2021 ident: B10 article-title: Integrated analysis of multimodal single-cell data publication-title: Cell doi: 10.1016/j.cell.2021.04.048 – volume: 191 year: 2013 ident: B19 article-title: Cx3cr1 regulates the maintenance of Klrg1(+) nk cells into the bone marrow by promoting their entry into circulation publication-title: J Immunol doi: 10.4049/jimmunol.1300090 |
| SSID | ssj0000493335 |
| Score | 2.473932 |
| Snippet | Alzheimer’s disease (AD) is the most common dementia without an effective cure at least partially due to incomplete understanding of the disease. Inflammation... Alzheimer's disease (AD) is the most common dementia without an effective cure at least partially due to incomplete understanding of the disease. Inflammation... |
| SourceID | doaj pubmedcentral proquest pubmed crossref |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
| StartPage | 1004885 |
| SubjectTerms | Alzheimer Disease - genetics Alzheimer’s disease CD56 Antigen - analysis CD56 Antigen - genetics cytotoxicity Humans Immunity, Innate Immunology innate immunity Killer Cells, Natural natural killer cell single cell sequencing Transcriptome |
| Title | Alzheimer’s disease alters the transcriptomic profile of natural killer cells at single-cell resolution |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/36405736 https://www.proquest.com/docview/2738493480 https://pubmed.ncbi.nlm.nih.gov/PMC9666759 https://doaj.org/article/756b6ad290794a50b059d8e162f0d7e4 |
| Volume | 13 |
| WOSCitedRecordID | wos000885627000001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 1664-3224 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000493335 issn: 1664-3224 databaseCode: DOA dateStart: 20100101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVHPJ databaseName: ROAD: Directory of Open Access Scholarly Resources (ISSN International Center) customDbUrl: eissn: 1664-3224 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000493335 issn: 1664-3224 databaseCode: M~E dateStart: 20100101 isFulltext: true titleUrlDefault: https://road.issn.org providerName: ISSN International Centre |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwEB5BBRIXxJvlURmJG4qadfzKsaBWXKg4gLQ3y081sJtFmyxSe6j6N_h7_SUdO-lqFyG4cImU2EmcmXH8fbZnBuCtoLXjVIXCWScLFr0olDWm4N6b4E0dJI052YQ8OVGzWf15K9VX2hM2hAceBHcgubDCeIokrmaGlxbxgFdhKmgsvQw5EigWbZGpbwPuraqKD14yyMLqg9gsFmvkg5SmjQFotnxnJMoB-_-EMn_fLLk1-hw_gPsjbCSHQ3Mfwq3QPoK7QyLJs8fQHM7PT0OzCKury18dGVddSF4K7whiPNKnMSn_IZIbMhlTdZNlJDm0Jz77e_YKJGkmvyOmJ2kSYY7SxXOCnHw00Sfw9fjoy4ePxZhEoXBMqL4Q0cvoEBSFamqco55zo2IZy4DUBdmdD8ZEhIFWRSVYUNYz4Rzz1tiqNJxVT2GvXbbhORDnsMt6FaeRWRzYlZEc8YcVpZSela6cwPRGoNqNEcZToou5RqaRlKCzEnRSgh6VMIF3m3t-DPE1_lr7fdLTpmaKjZ0voMXo0WL0vyxmAm9utKyxLyUxmjYs151ObkpoOEzhpzwbtL55VSUStK3EBOSOPey0ZbekbU5zvG5klEjL6hf_o_Ev4V4SSPaGpK9gr1-tw2u44372Tbfah9typvZzV8Djp4uja_ONErc |
| linkProvider | Directory of Open Access Journals |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Alzheimer%27s+disease+alters+the+transcriptomic+profile+of+natural+killer+cells+at+single-cell+resolution&rft.jtitle=Frontiers+in+immunology&rft.au=Qi%2C+Caiyun&rft.au=Liu%2C+Fang&rft.au=Zhang%2C+Wenjun&rft.au=Han%2C+Yali&rft.date=2022-11-02&rft.eissn=1664-3224&rft.volume=13&rft.spage=1004885&rft_id=info:doi/10.3389%2Ffimmu.2022.1004885&rft_id=info%3Apmid%2F36405736&rft.externalDocID=36405736 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1664-3224&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1664-3224&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1664-3224&client=summon |